17
7+(5$3,(81,76<0%2/(1
'HEHGLHQHUPRHWGLWGRFX
PHQWJHEUXLNVDDQZLM]LQJ
OH]HQYRRUJHEUXLN
/HWRS'LWV\PERROLV
EODXZRSKHWSURGXFWODEHO
2
8LW
6FKDNHOWGH
YRHGLQJXLW
,
$DQ
(OHNWULVFK
6FKDNHOWGH
YRHGLQJDDQ
*HFODVVLILFHHUGPHWEHWUHN
NLQJWRWHOHNWULVFKHVFKRN
NHQEUDQGHQPHFKDQLVFKH
ULVLFR¶VDOOHHQLQRYHUHHQ
VWHPPLQJPHW&$1&6$
&QXPPHU
$16,
$$0,(6
$0'
0(',6&+($33$5$7885
'XEEHO
JHwVROHHUG
7\SH%)
5DDGSOHHJGLWGRFXPHQW
JHEUXLNVDDQZLM]LQJYRRU
HHQEHVFKULMYLQJYDQ
GH SURGXFWFODVVLILFDWLH
H HGLWLH
6HULHQXP
PHU
$UWLNHOQXPPHU
&(PDUNHULQJGLHFRQIRU
PLWHLWDDQGXLGWPHWGH
JHKDUPRQLVHHUGHZHWJH
YLQJYDQGH(XURSHVH8QLH
$IEHHOGLQJHQGXLGHQWRH
]LFKWYDQHHQDDQJHPHOGH
LQVWDQWLH1RWLILHG
%RG\ DDQ
1LHWPHW
KXLVYXLO
PHHJHYHQ
)DEULNDQW'LW
V\PERROZRUGW
YHUJH]HOGYDQGH
QDDPHQKHW
DGUHVYDQGH
IDEULNDQW
5DDGSOHHJGLWGRFXPHQW
JHEUXLNVDDQZLM]LQJYRRU
HHQEHVFKULMYLQJYDQ
GH SURGXFWFODVVLILFDWLH
H HGLWLH
*HYDDUOLMN
YROWDJH
3URGXFWLHGDWXP
'XLGWDDQGDWKHWSURGXFW
HHQPHGLVFKKXOSPLGGHOLV
LQRYHUHHQVWHPPLQJPHW
(8YHURUGHQLQJEHWUHI
IHQGHPHGLVFKHKXOSPLG
GHOHQ
0,/,(8,1)250$7,(WKHUDSLHXQLW
7RHVWDQG
7HPSHUDWXXUEHUHLN
5HODWLHYHYRFKWLJKHLG
/XFKWGUXN
%HGLHQLQJ
&WRW&
)WRW)
WRW
QLHWFRQGHQVHUHQG
K3DWRWK3D
2SVODJODQJGXULJ
&WRW&
)WRW)
WRW
QLHWFRQGHQVHUHQG
K3DWRWK3D
2SVODJWLMGHOLMN
&WRW&
)WRW)
WRW
QLHWFRQGHQVHUHQG
K3DWRWK3D
/(723
Als de therapie-unit is opgeslagen in omstandigheden buiten de normale werkingsomstandig-
heden, moet hij vóór gebruik bij normale werkingsomstandigheden gestabiliseerd worden.
E348583
(2008) + (2014)
ANSI/AAMI ES 60601-1
(2005) +AMD (2012)
i
SN
REF
Summary of Contents for Alpha Active 4
Page 158: ...23 HORZR SXVWH...